A01=Antonio C. Bianco
A01=Dr. Antonio C. Bianco
A01=MD
Age Group_Uncategorized
Age Group_Uncategorized
alternative
Author_Antonio C. Bianco
Author_Dr. Antonio C. Bianco
Author_MD
automatic-update
big
big pharma
brain
Category1=Non-Fiction
Category=VFJB
Category=VFJB9
chronic
chronic illness
confusion
COP=United States
Delivery_Delivery within 10-20 working days
diagnose
diagnosis
disease
edocrine
endocrinology
energy
eq_bestseller
eq_health-lifestyle
eq_isMigrated=2
eq_nobargain
eq_non-fiction
foggy
foggy brain
hashimotos
hashimotos disease
health
health and wellness
healthcare
hormone
hormone levels
illness
imbalance
Language_English
level
management
MD
medicine
memory
metabolism
non-pharmaceutical
nonfiction
nutrition
PA=Available
patients
pharma
prescription
Price_€20 to €50
PS=Active
reference
remedy
replacement
science
self
softlaunch
t4
thyroid
thyroid conditions
thyroxine
treat
treatment
treatments
Product details
- ISBN 9780226823164
- Weight: 367g
- Dimensions: 140 x 216mm
- Publication Date: 24 Nov 2022
- Publisher: The University of Chicago Press
- Publication City/Country: US
- Product Form: Paperback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
In this primer for patients, their families, and their doctors, a leading physician and scientist explains why the standard treatment for hypothyroidism fails many—and offers an empowering call for change.
Hypothyroidism, also commonly referred to as Hashimoto’s disease, affects millions in the United States alone. It occurs when the thyroid—the butterfly-shaped gland that sits in your neck right above the front of your shirt collar—malfunctions or after thyroid surgery, causing thyroid hormone levels in circulation to drop below normal. Thus, treatment is aimed at bringing these hormone levels back to normal. This is done with daily tablets of thyroxine or T4. Because hypothyroidism is so common, we likely know someone who is on this type of medication. While most patients respond well to this standard treatment, about ten to twenty percent (some two to three million individuals in the United States) are far from living a typical life. They exhibit “foggy brain”—low energy, confusion, and poor memory. Many doctors have shrugged off their complaints, believing these symptoms to be unrelated to the thyroid disease. In Rethinking Hypothyroidism, Dr. Antonio C. Bianco, a physician and a scientist who has studied hypothyroidism and thyroid hormones for decades, offers an accessible overview of the disease’s treatment and the role of big pharma in shaping it, making the case that the current approach is failing many patients. But more than this, Bianco calls for alternatives to improve lives, and he equips patients and their families with the tools to advocate for other treatments.
Hypothyroidism, also commonly referred to as Hashimoto’s disease, affects millions in the United States alone. It occurs when the thyroid—the butterfly-shaped gland that sits in your neck right above the front of your shirt collar—malfunctions or after thyroid surgery, causing thyroid hormone levels in circulation to drop below normal. Thus, treatment is aimed at bringing these hormone levels back to normal. This is done with daily tablets of thyroxine or T4. Because hypothyroidism is so common, we likely know someone who is on this type of medication. While most patients respond well to this standard treatment, about ten to twenty percent (some two to three million individuals in the United States) are far from living a typical life. They exhibit “foggy brain”—low energy, confusion, and poor memory. Many doctors have shrugged off their complaints, believing these symptoms to be unrelated to the thyroid disease. In Rethinking Hypothyroidism, Dr. Antonio C. Bianco, a physician and a scientist who has studied hypothyroidism and thyroid hormones for decades, offers an accessible overview of the disease’s treatment and the role of big pharma in shaping it, making the case that the current approach is failing many patients. But more than this, Bianco calls for alternatives to improve lives, and he equips patients and their families with the tools to advocate for other treatments.
Antonio C. Bianco, MD, is professor of medicine and a member of the Committee on Molecular Metabolism and Nutrition at the University of Chicago, where he runs a laboratory funded by the National Institutes of Health to study thyroid hormones. Bianco is also a former president of the American Thyroid Association.
